| Financial Year |
March 31 2023 |
| Monetary Funds |
53,819,321.07 |
| Held-for-trading Financial Assets |
162,314,104.10 |
| Notes Receivable |
33,671,732.10 |
| Accounts Receivable |
185,370,533.65 |
| Advances to Suppliers |
9,252,287.94 |
| Other Receivables |
2,299,540.42 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
90,717,615.35 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,470,180.22 |
| Total Current Assets |
551,712,379.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
16,871,921.01 |
| Investment Properties |
-- |
| Fixed Assetes |
269,777,000.58 |
| Under-construction Projects |
6,152,131.84 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
25,656,525.06 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,423,127.98 |
| Deferred Income Tax Assets |
10,309,671.60 |
| Other Non-Current Assets |
14,496,375.17 |
| Sub-Total of Non-Current Assets |
351,214,751.27 |
| Total Assets |
902,927,130.87 |
| Short-Term Loans |
9,821,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,892,232.58 |
| Accounts Payable |
36,196,479.01 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,863,130.33 |
| Taxes Payable |
6,933,149.63 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,229,605.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,418,495.10 |
| Other Current Liabilities |
307,902.62 |
| Sub-Total of Current Liabilities |
85,614,260.80 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
581,315.28 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
7,191,187.08 |
| Total Liabilities |
92,805,447.88 |
| Paid-In Capital(Or Share Stock) |
127,980,000.00 |
| Capital Surplus |
429,256,181.62 |
| Surplus Reserve |
22,805,748.63 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
224,812,517.96 |
| Minority Stockholder's Interest |
5,270,734.78 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
804,850,948.21 |
| Owner's Equity（Stockholder's Equity） |
810,121,682.99 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
902,927,130.87 |
